Chicago, Illinois
United States
10
2019-09-26
10
2020-12-15
These are the the leading inventors for applications assigned to AbbVie Inc.:
AbbVie Inc. based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
High purity oritavancin and method of producing same
#2 | 2018-03-08 ✅ Patent 10,730,873 granted on 2020-08-04Salts and crystalline forms of an apoptosis-inducing agent
#3 | 2017-06-08 ✅ Patent 10,328,118 granted on 2019-06-25High purity oritavancin and method of producing same
#4 | 2016-08-18 ✅ Patent 9,499,616 granted on 2016-11-22Modulated lysine variant species compositions and methods for producing and using the same
#5 | 2016-01-21 ✅ Patent 9,649,352 granted on 2017-05-16High purity oritavancin and method of producing same
#6 | 2014-12-04 ✅ Patent 9,481,736 granted on 2016-11-01IL-17 binding proteins
#7 | 2014-11-20 ✅ Patent 9,481,735 granted on 2016-11-01IL-17 binding proteins
#8 | 2014-05-08 ✅ Patent 9,956,353 granted on 2018-05-01Shroud deployment in automatic injection devices
#9 | 2012-10-04 ✅ Patent 10,464,987 granted on 2019-11-05Human single-chain T cell receptors
#10 | 2011-12-22 ✅ Patent 9,170,262 granted on 2015-10-27Comparison of protein samples
Also check out AbbVie Inc.'s (Chicago, United States) applicant profile with 4 patent applications submitted.
64244 ⎘